Related references
Note: Only part of the references are listed.Sublingual vaccination
Cecil Czerkinsky et al.
HUMAN VACCINES (2011)
Heterogeneity of the humoral immune response following Staphylococcus aureus bacteremia
N. J. Verkaik et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2010)
Health Care-Associated Invasive MRSA Infections, 2005-2008
Alexander J. Kallen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Heat-stable oral alga-based vaccine protects mice from Staphylococcus aureus infection
Imke A. J. Dreesen et al.
JOURNAL OF BIOTECHNOLOGY (2010)
Community-associated meticillin-resistant Staphylococcus aureus
Frank R. DeLeo et al.
LANCET (2010)
Purification and characterization of Yersinia enterocolitica and Yersinia pestis LcrV-cholera toxin A2/B chimeras
Juliette K. Tinker et al.
PROTEIN EXPRESSION AND PURIFICATION (2010)
Mucosally induced Immunological Tolerance, Regulatory T Cells and the Adjuvant Effect by Cholera Toxin B Subunit
J-B. Sun et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2010)
Sublingual immunization with an HIV subunit vaccine induces antibodies and cytotoxic T cells in the mouse female genital tract
Catherine Hervouet et al.
VACCINE (2010)
IsdA and IsdB antibodies protect mice against Staphylococcus aureus abscess formation and lethal challenge
Hwan Keun Kim et al.
VACCINE (2010)
The Panton-Valentine leukocidin vaccine protects mice against lung and skin infections caused by Staphylococcus aureus USA300
E. L. Brown et al.
CLINICAL MICROBIOLOGY AND INFECTION (2009)
Iron-Regulated Surface Determinant Protein A Mediates Adhesion of Staphylococcus aureus to Human Corneocyte Envelope Proteins
Simon R. Clarke et al.
INFECTION AND IMMUNITY (2009)
Transient Facial Nerve Paralysis (Bell's Palsy) following Intranasal Delivery of a Genetically Detoxified Mutant of Escherichia coli Heat Labile Toxin
David J. M. Lewis et al.
PLOS ONE (2009)
Intranasal vaccination of calves with Mannheimia haemolytica chimeric protein containing the major surface epitope of outer membrane lipoprotein PlpE, the neutralizing epitope of leukotoxin, and cholera toxin subunit B
S. Ayalew et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2009)
Direct hemin transfer from IsdA to IsdC in the iron-regulated surface determinant (Isd) heme acquisition system of Staphylococcus aureus
Mengyao Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Cholera toxin, E-coli heat-labile toxin, and non-toxic derivatives induce dendritic cell migration into the follicle-associated epithelium of Peyer's patches
N. G. Anosova et al.
MUCOSAL IMMUNOLOGY (2008)
Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005
Eili Klein et al.
EMERGING INFECTIOUS DISEASES (2007)
Induction of cell signaling events by the cholera toxin B subunit in antigen-presenting cells
Aletta C. Schnitzler et al.
INFECTION AND IMMUNITY (2007)
The Staphylococcus aureus surface protein IsdA mediates resistance to innate Defenses of human skin
Simon R. Clarke et al.
CELL HOST & MICROBE (2007)
Haem recognition by a Staphylococcus aureus NEAT domain
Jason C. Grigg et al.
MOLECULAR MICROBIOLOGY (2007)
Vaccine assembly from surface proteins of Staphylococcus aureus
Yukiko K. Stranger-Jones et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Characterization of the heme binding properties of Staphylococcus aureus IsdA
Christie L. Vermeiren et al.
BIOCHEMISTRY (2006)
Identification of in vivo-expressed antigens of Staphylococcus aureus and their use in vaccinations for protection against nasal carriage
SR Clarke et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus
BA Diep et al.
LANCET (2006)
Immunomodulation with enterotoxins for the generation of secretory immunity or tolerance: Applications for oral infections
G Hajishengallis et al.
JOURNAL OF DENTAL RESEARCH (2005)
Enterotoxin-based mucosal adjuvants alter antigen trafficking and induce inflammatory responses in the nasal tract
FW van Ginkel et al.
INFECTION AND IMMUNITY (2005)
Characterization of fluorescent chimeras of cholera toxin and Escherichia coli heat-labile enterotoxins produced by use of the twin arginine translocation system
JK Tinker et al.
INFECTION AND IMMUNITY (2005)
Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA
J Holmgren et al.
IMMUNOLOGY LETTERS (2005)
Nasal carriage of Staphylococcus aureus and prevention of nosocomial infections
JAJW Kluytmans et al.
INFECTION (2005)
Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland
M Mutsch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers
HFL Wertheim et al.
LANCET (2004)
Use of translational fusion of the MrpH fimbrial adhesin-binding domain with the cholera toxin A2 domain, coexpressed with the cholera toxin B subunit, as an intranasal vaccine to prevent experimental urinary tract infection by Proteus mirabilis
X Li et al.
INFECTION AND IMMUNITY (2004)
Complete genomes of two clinical Staphylococcus aureus strains:: Evidence for the rapid evolution of virulence and drug resistance
MTG Holden et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
An enzymatically active A domain is required for cholera-like enterotoxins to induce a long-lived blockade on the induction of oral tolerance: New method for screening mucosal adjuvants
KC Bagley et al.
INFECTION AND IMMUNITY (2003)
Cholera holotoxin assembly requires a hydrophobic domain at the A-B5 interface:: Mutational analysis and development of an in vitro assembly system
JK Tinker et al.
INFECTION AND IMMUNITY (2003)
Mucosal immunization with a genetically engineered pertussis toxin S1 fragment-cholera toxin subunit B chimeric protein
SF Lee et al.
INFECTION AND IMMUNITY (2003)
Cholera toxin and its B subunit promote dendritic cell vaccination with different influences on Th1 and Th2 development
K Eriksson et al.
INFECTION AND IMMUNITY (2003)
Cholera toxin activates dendritic cells through dependence on GM1-ganglioside which is mediated by NF-kappa B translocation
YI Kawamura et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
An iron-regulated sortase anchors a class of surface protein during Staphylococcus aureus pathogenesis
SK Mazmanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Transferrin binding in Staphylococcus aureus: involvement of a cell wall-anchored protein
JM Taylor et al.
MOLECULAR MICROBIOLOGY (2002)
Cholera toxin B subunit as a carrier molecule promotes antigen presentation and increases CD40 and CD86 expression on antigen-presenting cells
A George-Chandy et al.
INFECTION AND IMMUNITY (2001)
Kinetics and type of immune response following intranasal and subcutaneous immunisation of calves
MC Rebelatto et al.
RESEARCH IN VETERINARY SCIENCE (2001)
Mucosal vaccination with recombinantly attenuated staphylococcal enterotoxin B and protection in a murine model
BG Stiles et al.
INFECTION AND IMMUNITY (2001)
Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants
M Pizza et al.
VACCINE (2001)
Effects of intranasal administration of cholera toxin (or Escherichia coli heat-labile enterotoxin) B subunits supplemented with a trace amount of the holotoxin on the brain
Y Hagiwara et al.
VACCINE (2001)
Share Paper
